- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 144-158 of
300 results
1032 Exhibit: Klebanoff
Document
IPR2022-00855, No. 1032-28 Exhibit - Klebanoff (P.T.A.B. Apr. 12, 2022)
|
|
Cite Document
1034 Exhibit: Mosteller
Document
IPR2022-00855, No. 1034-30 Exhibit - Mosteller (P.T.A.B. Apr. 12, 2022)
|
|
Cite Document
1046 Exhibit: Brentjens
Document
IPR2022-00855, No. 1046-41 Exhibit - Brentjens (P.T.A.B. Apr. 12, 2022)
|
|
Cite Document
1052 Exhibit: Arnold Declaration
Document
IPR2022-00855, No. 1052-45 Exhibit - Arnold Declaration (P.T.A.B. Apr. 12, 2022)
|
|
Cite Document
2023 Exhibit: Andrew Pollock, Setting the Body���s ���Serial Killers��� Loose on Canc...
Document
IPR2022-00855, No. 2023-69 Exhibit - Andrew Pollock, Setting the Body���s ���Serial Killers��� Loose on Cancer, NY TIMES Aug 1, 2016, httpswwwnytimescom20160802healthcancer cell therapy...
|
|
Cite Document
2015 Exhibit: Jennifer Couzin Frankel, The dizzying journey to a new cancer arsena...
Document
IPR2022-00855, No. 2015-61 Exhibit - Jennifer Couzin Frankel, The dizzying journey to a new cancer arsenal, 340 SCI 1514 2013 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
2035 Exhibit: Grazyna Lipowska Bhalla, Targeted immunotherapy of cancer with CA...
Document
IPR2022-00855, No. 2035-81 Exhibit - Grazyna Lipowska Bhalla, Targeted immunotherapy of cancer with CAR T cells achievements and challenges, 61 CANCER IMMUNOLOGY, IMMUNOTHER...
|
|
Cite Document
2031 Exhibit: Steven A Rosenberg et al, Use of Tumor Infiltrating Lymphocytes and...
Document
IPR2022-00855, No. 2031-77 Exhibit - Steven A Rosenberg et al, Use of Tumor Infiltrating Lymphocytes and Interleukin 2 in the Immunotherapy of Patients with Metastatic Melanoma, 319 NEW E...
|
|
Cite Document
2034 Exhibit: David L Porter et al, A phase 1 trial of donor lymphocyte infusions exp...
Document
IPR2022-00855, No. 2034-80 Exhibit - David L Porter et al, A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3CD28 costimulation, 107 BLOOD 1325 2006 (P.T...
|
|
Cite Document
2009 Exhibit: FOOD AND DRUG ADMIN, PRIORITY REVIEW Jan 4, 2018, httpswww...
Document
IPR2022-00855, No. 2009-55 Exhibit - FOOD AND DRUG ADMIN, PRIORITY REVIEW Jan 4, 2018, httpswwwfdagovpatientsfast track breakthrough therapy accelerated approval priority reviewp...
|
|
Cite Document
2008 Exhibit: FOOD AND DRUG ADMIN, BREAKTHROUGH THERAPY Jan 4, 2018...
Document
IPR2022-00855, No. 2008-54 Exhibit - FOOD AND DRUG ADMIN, BREAKTHROUGH THERAPY Jan 4, 2018, httpswwwfdagovpatientsfast track breakthrough therapy accelerated approval priorit...
|
|
Cite Document
2039 Exhibit: Cor HJ Lamers et al, Treatment of Metastatic Renal Cell Carcinoma W...
Document
IPR2022-00855, No. 2039-85 Exhibit - Cor HJ Lamers et al, Treatment of Metastatic Renal Cell Carcinoma With Autologous T Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX...
|
|
Cite Document
2015 Exhibit: Jennifer Couzin Frankel, The dizzying journey to a new cancer arsena...
Document
IPR2022-00855, No. 2015-61 Exhibit - Jennifer Couzin Frankel, The dizzying journey to a new cancer arsenal, 340 SCI 1514 2013 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
1038 Exhibit: NCT01029366 webpage
Document
IPR2022-00855, No. 1038-34 Exhibit - NCT01029366 webpage (P.T.A.B. Apr. 12, 2022)
|
|
Cite Document
2029 Exhibit: Pilot Study for Patients with Chemotherapy Resistant or Refractory C...
Document
IPR2022-00855, No. 2029-75 Exhibit - Pilot Study for Patients with Chemotherapy Resistant or Refractory CD19 Leukemia and Lymphoma CART 19, CLINICALTRIALSGOV April 29, 2009, httpwe...
|
|
Cite Document
